FOF/PE  Omega Funds

     Office Locations:

185 Dartmouth Street, Suite 502
Boston, MA 02116

Get all office locations for this firm with a National Database subscription.


  • Expansion
  • Late



  • Life Sciences & Healthcare



    Omega Funds was established in 2004, and manages six funds with investments across Europe, North America and the Far East. Omega invests in both public and private companies, completing investments across all healthcare sectors, including biotech, medtech, diagnostics, services and healthcare IT since inception.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Anne-Mari Paster CFO
    Otello Stampacchia PhD Partner
    Renee Aguiar-Lucander Partner
    Richard Lim Partner
    Vincent Ossipow PhD, CFA Venture Partner


    Recent Funding Events (trailing 12 months):







      Gossamer Bio



      Seed and Series A





      Series C





      Series B


      Trevi Therapeutics



      Series C


    Portfolio companies include:


    Recent News: